Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-01-01 @ 9:45 PM
Study NCT ID:
NCT05107856
Status:
TERMINATED
Last Update Posted:
2024-01-31
First Post:
2021-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
Sponsor:
Prelude Therapeutics
Organization: